Publication | Closed Access

Inhibition of tumor cell-induced platelet aggregation using a novel anti-podoplanin antibody reacting with its platelet-aggregation-stimulating domain

ThrombopoiesisThrombosisBlood PlateletMedicineHematologyImmunologyPlatelet AntagonistNovel Anti-podoplanin AntibodyTumor TargetingPlatelet-aggregation-stimulating DomainImmunotherapyPharmacologyAnticoagulantTumor MicroenvironmentTumor BiologyPlatelet Activation